If you dey waka waka anyhow thinking that if you contract gono, you would easily take some drugs and it would disappear, you better start thinking twice.

The health agency of the United Nations is warning that the sexually transmitted disease is developing resistance to existing antibiotics.

Nearly 80 million people are infected with the disease every year, the World Health Organization (WHO) said in a statement.

Among these, doctors are finding more and more cases of infections untreatable by all known antibiotics.

“To control gonorrhoea, we need new tools and systems for better prevention, treatment, earlier diagnosis,” said WHO’s director of antimicrobial resistance, Marc Sprenger.

“We need new antibiotics, as well as rapid, accurate, point-of-care diagnostic tests.”

Gonorrhoea, also called “the clap”, is a disease caused by a bacteria spread through vaginal, oral and anal sex.

Untreated, it can cause painful pelvic inflammation in women, and infertility in both genders. In extreme cases, the bacteria can spread in the blood to cause life-threatening infections in other parts of the body.

It can be passed directly from a pregnant woman to her baby and causes blindness in the unborn child.

Resistance to the next level antibiotic, ciprofloxacin, developed in the mid-2000s.

“But resistance to cefixime, and more rarely to ceftriaxone, has now been reported in more than 50 countries,” said the WHO.

These are so-called multi-drug resistant (MDR) strains.

“The bacteria that cause gonorrhoea are particularly smart,” said WHO official Teodora Wi.

“Every time we use a new class of antibiotics to treat the infection, the bacteria evolve to resist them.”

Most countries reporting a rise in MDR gonorrhea are in the developed world, where surveillance is best.

“These cases may just be the tip of the iceberg, since systems to diagnose and report untreatable infections are lacking in lower income countries where gonorrhea is actually more common,” said Wi.

As a result, the agency last year updated its treatment recommendations, urging doctors to use two antibiotics combined: ceftriaxone and azithromycin.